Request a Depo-Provera case review.
Tell us about your Depo-Provera injections and any meningioma diagnosis or related symptoms. David Meldofsky refers your request to a participating law firm that handles this category in your state.
Lawsuit Center is the intake and referral practice of David Meldofsky, a California attorney, and provides no legal advice through this site. Submitting information does not guarantee eligibility, compensation, contact, or representation.
Situations people often research.
These claims involve long-term use of the injectable contraceptive, followed by a meningioma diagnosis. That includes Depo-Provera CI, Depo-SubQ Provera 104 and authorized generic medroxyprogesterone acetate. You do not need to know the legal terms. Three facts are enough to start: how long the injections went on, when symptoms began, and what the diagnosis was.
- Years of Depo-Provera, Depo-SubQ Provera 104 or generic MPA shots, then a meningioma diagnosis
- Brain or spine surgery, radiation, or regular scans to watch a meningioma
- Headaches, vision changes, seizures or memory problems that led to imaging
- A family member diagnosed after years of injections
- Pharmacy or clinic records showing injections over several years
- More than one meningioma found
Sign-ups close November 30, 2026.
In June 2026, Pfizer and the lawyers leading the federal Depo-Provera cases reached an agreement in principle to settle the meningioma claims. On October 16, those lead lawyers told the court that registration for the settlement program is open and closes on November 30, 2026.
The court filing leaves out the parts most people want to know. It does not state who is eligible, how payments will be calculated, or how an individual registers. Pfizer and the lead lawyers have kept those rules private so far.
If you already have a lawyer, ask that lawyer whether you have been registered. If you do not, November 30 is the date to work back from. A firm needs time to collect your injection records and diagnosis before it can register anyone. A review request made this week leaves more room than one made the week of Thanksgiving.
The sign-up date and your state's filing deadline are two different clocks. State deadlines usually run from the date of diagnosis, and the settlement announcement did not pause them. A review looks at both.
Depo-Provera case review form.
Start with the situation that best fits, then briefly describe what happened. Contact information is requested so the firm David refers your request to can follow up before the November 30 sign-up date.
What happens next.
Your information is used to match your request to an active lawsuit category and to a participating law firm in your state.
If there appears to be a possible fit, David refers your request to a participating law firm, and that firm may contact you to ask for more information.
No attorney-client relationship is formed unless and until you sign an agreement directly with a law firm.
Where Depo-Provera claims are being handled.
The federal cases are consolidated in a multidistrict litigation in the Northern District of Florida, MDL 3140, before Judge M. Casey Rodgers. The court appointed a settlement administrator, a fund administrator and a lien administrator over the late summer, and in September it opened a separate docket just for settlement business.
Pfizer is still fighting the cases that stay outside the settlement. Its main argument is federal preemption: Pfizer says the FDA would have rejected the stronger meningioma warning these lawsuits say was missing, so federal law blocks the claims. The women's lawyers answer those papers at the end of October, and the judge has not ruled.
A separate group of cases is pending in state courts, with the largest groups in Delaware, New York, California and Minnesota. Which court a claim belongs in depends on where the woman lives and where she was treated, and the firm that reviews it sorts that out.
Filing counts, order dates and the status of each motion change month to month. The Depo-Provera lawsuit updates page on Lawsuit Informer carries the current record.
What people often gather beforehand.
Nothing on this list is required to submit the form. It is what a firm asks for next, and in this litigation every woman in the federal cases has to prove both her injections and her diagnosis.
- Pharmacy, clinic or insurance records showing the injections, with the first and last dates
- The product name on those records: Depo-Provera, Depo-SubQ Provera 104 or generic medroxyprogesterone acetate
- The MRI or CT report that found the meningioma, and the pathology report if it was removed
- The date of diagnosis, which sets most state deadlines
- Surgery, radiation or monitoring records, and the name of the treating neurosurgeon or oncologist
- Any note from a doctor connecting the meningioma to the injections, though most people do not have one
Questions people ask first.
Does the settlement mean I will be paid?
Nobody can answer that yet. Pfizer and the lead lawyers have agreed to a program but have published neither the eligibility rules nor the payment formula. A review can tell you whether your injection history and diagnosis fit the pattern these cases share, and a firm can register you if they do.
I already have a lawyer. Should I still submit?
Call your lawyer first and ask whether your case has been registered for the settlement and whether your proof of injections and diagnosis has been accepted by the court. Your own lawyer is the person who can answer that. This form is for people who do not yet have one.
I do not have my injection records.
Most people do not have them at hand. The clinic, the pharmacy and your insurer each keep a record of the shots, and a firm requests those as part of its work-up. What helps most is knowing roughly when the injections started and stopped and where you got them.
I used Depo-Provera for less than a year.
Submit anyway and say so. Most of the cases involve years of injections, and the warning the FDA approved in December 2025 ties the risk mostly to long-term use, so firms weigh duration heavily. Whether a shorter history fits depends on the rest of the facts, and the review is where that gets looked at.
Read this before submitting.
Lawsuit Center is the intake and referral practice of David Meldofsky, a California attorney, and provides no legal advice through this site. Submitting information creates no attorney-client relationship. It does not guarantee that you qualify for a claim, that compensation will be available, or that any law firm will offer representation.
Some pages may include attorney advertising, sponsored listings, paid law firm visibility, or referral-related opportunities. Sponsored visibility is advertising and should not be treated as a recommendation or endorsement of any attorney or law firm.
Pfizer and the lawyers leading the federal cases agreed in principle to settle in June 2026, and registration for the settlement program closes November 30, 2026. The written terms remain private, and some cases will stay outside the program. The announcement paused no legal deadline.
Legal deadlines for Depo-Provera and meningioma claims can vary by state and can be short. Some states have pharmaceutical immunity statutes or statutes of repose that may also affect claims. If you believe you may have a claim, consider speaking with a licensed attorney as soon as possible.